Results 71 to 80 of about 11,913 (306)

Tests of robustness of GMM speaker verification in VoIP telephony

open access: yesArchives of Acoustics, 2014
The paper presents the scores of the GMM (Gaussian Mixture Models) based speaker verification system for speech signal transmitted in VoIP (Voice over IP) telephony conditions.
Piotr Staroniewicz
doaj  

Hijacking emergency granulopoiesis: Neutrophil ontogeny and reprogramming in cancer

open access: yesMolecular Oncology, EarlyView.
Neutrophils are highly plastic innate immune cells; their functions in cancer extend beyond the tumour microenvironment. This Review summarises current understanding of neutrophil maturation and heterogeneity and highlights tumour‐induced granulopoiesis as a systemic programme that expands immature, immunosuppressive neutrophils via tumour‐derived ...
Gabriela Marinescu, Yi Feng
wiley   +1 more source

Bayes factor scoring of GMMs for speaker verification [PDF]

open access: yes, 2004
This paper implements and assesses the Bayes factor as a replacement verification criterion to the likelihood-ratio test in the context of GMM-based speaker verification.
Vogt, Robert J., Sridharan, Sridha
core  

Utterance Verification for Text-Dependent Speaker Recognition:A Comparative Assessment Using the RedDots Corpus [PDF]

open access: yes, 2016
Text-dependent automatic speaker verification naturally calls for the simultaneous verification of speaker identity and spoken content. These two tasks can be achieved with automatic speaker verification (ASV) and utterance verification (UV) technologies.
Kukanov, Ivan   +22 more
core   +1 more source

Longitudinal circulating tumor DNA profiling in patients with advanced endometrial cancer using an off‐the‐shelf targeted NGS panel

open access: yesMolecular Oncology, EarlyView.
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena   +15 more
wiley   +1 more source

Improving automatic speaker verification using SVM techniques [PDF]

open access: yes, 2009
Automatic recognition of people is an active field of research with important forensic and security applications. In these applications, it is not always possible for the subject to be in close proximity to the system.
McLaren, Mitchell Leigh
core  

Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining

open access: yesMolecular Oncology, EarlyView.
IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis   +3 more
wiley   +1 more source

Speaker verification with elicited speaking-styles in the Verivox project [PDF]

open access: yes, 1998
Some experiments to take care of within speaker variations in speaker verification has been performed. To get speaker variation, speaking behaviour elicitation software has been developed.
Karlsson, Inger A.,   +7 more
core  

Effects of gender information in text-independent and text-dependent speaker verification [PDF]

open access: yes, 2017
It is well-known that for speaker recognition task, gender-dependent acoustic modeling performs better than gender-independent modeling. The practice is to use the gender ground-truth and to train gender-dependent models. However, such information is not
Md Sahidullah   +9 more
core   +1 more source

Longitudinal genome‐wide aneuploidy measurements in circulating cell‐free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer

open access: yesMolecular Oncology, EarlyView.
Many patients with urothelial cancer do not benefit from treatment with pembrolizumab, while at risk of severe side effects. Changes in the levels of circulating tumor DNA early during treatment, measured by a simple and affordable assay that can be easily implemented in the clinic, can be used as a prognostic tool to identify these patients.
Youssra Salhi   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy